Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-26

Clinical Trial Update: Trial of Olaparib in Combination With AZD5363 (ComPAKT) [Phase 1]

View source ↗

Summary

A Phase 1 trial of olaparib in combination with AZD5363 (ComPAKT) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AZD5363 (capivasertib)
  • Lynparza (olaparib)

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Advanced Cancer | Phase 1 | Status: COMPLETED